Lifecycle Planning
Lifecycle Planning
Effective planning throughout asset lifecycle can assure sustained franchise level revenue & profit optimization – MKTXS has the tools and experience to support your product post-launch
Indication Sequencing
MKTXS will identify the optimal launch order for assets with multiple indications based on inherent value in each indication while considering current/future competition, dosing variance, and line-extension policies at national/regional level
Product Franchise Revenue Impact
MKTXS has internal expertise to assess the price impact as a result of key market events including:
- Price increases
- Generic/biosimilar entry impact
- Cross border trades (CBT)
- International reference pricing (IRP)
MKTXS platforms used for Lifecycle Planning
MVAP
Market Access Value Assessment Platform
CARVE
Continued Access Reinforced by Value Evidence
PHARMA.AI
Pharmaceutical Analog Index